Skip to content
Disclosery

13F-HR filed by SUPERSTRING CAPITAL MANAGEMENT LP

SUPERSTRING CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 35 holding rows worth $101,502,599.

Accession
0001931118-25-000010
Filer
CIK 1931118
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 35 entries on the cover page, a total value of $101,502,599 stated on the cover page (in dollars after the unit check, H1), rows summing to $101,502,599 with VALUE read as dollars as filed, 13F file number 028-23866. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ZAI LAB LTD ADR98887Q104ADR200,628$6,799,283dollars as filed
CIDARA THERAPEUTICS INC171757206COM NEW68,463$6,556,017dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock789,646$5,930,241dollars as filed
89BIO INC282559103COM384,652$5,654,384dollars as filed
IMMUNOVANT INC45258J102COM341,348$5,502,530dollars as filed
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock40,893$5,389,697dollars as filed
COGENT BIOSCIENCES INC19240Q201COM361,408$5,189,819dollars as filed
SAVARA INC805111101COM1,309,236$4,673,973dollars as filed
BRIDGEBIO PHARMA INC10806X102COM88,658$4,604,897dollars as filed
SUMMIT THERAPEUTICS INC86627T108COM197,253$4,075,247dollars as filed
IQVIA HLDGS INC COM46266C105Stock19,114$3,630,513dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK1,544,525$3,614,189dollars as filed
REGENERON PHARMACEUTICALS COM75886F107Stock6,401$3,599,090dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK53,950$3,272,607dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK51,270$2,917,263dollars as filed
INSMED INC COM PAR $.01457669307Stock19,786$2,849,382dollars as filed
BICARA THERAPEUTICS INC055477103COM175,902$2,777,493dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK188,080$2,390,497dollars as filed
SANOFI SA SPONSORED ADR80105N105ADR50,407$2,379,210dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock96,665$2,145,963dollars as filed
UNIQURE NVN90064101SHS33,175$1,936,425dollars as filed
TECTONIC THERAPEUTIC INC878972108COMMON STOCK119,286$1,871,597dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK87,912$1,753,844dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK360,000$1,566,000dollars as filed
KEROS THERAPEUTICS INC COM492327101Stock95,083$1,504,213dollars as filed
SCHOLAR ROCK HLDG CORP80706P103COM39,521$1,471,762dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM20,358$1,352,382dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM53,627$1,281,685dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM89,346$1,072,152dollars as filed
RAPT THERAPEUTICS INC75382E208COM NEW34,449$888,440dollars as filed
VIR BIOTECHNOLOGY INC92764N102COM150,312$858,282dollars as filed
CORBUS PHARMACEUTICALS21833P301COM NEW57,644$729,197dollars as filed
NOVABRIDGE BIOSCIENCES44975P103CMN139,886$528,769dollars as filed
BIOMEA FUSION INC09077A106CMN250,000$505,000dollars as filed
CENTURY THERAPEUTICS INC15673T100COM462,963$230,556dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001931118-25-000010this filing2025-11-14acceptance time not in the bulk data set